Reversing cancer immunoediting phases with a tumor-activated and optically reinforced immunoscaffold
In situ vaccine (ISV) is a promising Handlebar Sensor Cable immunotherapeutic tactic due to its complete tumoral antigenic repertoire.However, its efficiency is limited by extrinsic inevitable immunosuppression and intrinsic immunogenicity scarcity.To break this plight, a tumor-activated and optically reinforced immunoscaffold (TURN) is exploited t